Search
Menu
Videology Industrial-Grade Cameras - Custom Embedded Cameras LB 2024

GE Healthcare

Facebook X LinkedIn Email
GE Healthcare of Chalfont St. Giles, UK, is set to dedicate $1 billion of its total R&D budget over the next five years to expanding its advanced cancer diagnostic and molecular imaging capabilities as well as its technologies for biopharmaceuticals manufacturing and for cancer research. Announced alongside a $100 million open innovation challenge in New York, the billion-dollar investment crosses all lines of GE Healthcare’s global business and will enable the company to bring the most promising cancer ideas to market. The company’s solutions combine medical imaging,...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: November 2011
    AmericasBiophotonicsBusinesscancer diagnosticscancer researchEnglandEuropeGE HealthcareImagingindustrialJohn Dineenlaboratory diagnosticsmedical imagingmolecular imagingNew YorkoncologyR&D expendituresRapidScan

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.